You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

IBUTILIDE FUMARATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ibutilide Fumarate, and when can generic versions of Ibutilide Fumarate launch?

Ibutilide Fumarate is a drug marketed by Luitpold and Mylan Institutional and is included in three NDAs.

The generic ingredient in IBUTILIDE FUMARATE is ibutilide fumarate. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ibutilide Fumarate

A generic version of IBUTILIDE FUMARATE was approved as ibutilide fumarate by MYLAN INSTITUTIONAL on January 11th, 2010.

  Try a Trial

Drug patent expirations by year for IBUTILIDE FUMARATE
Recent Clinical Trials for IBUTILIDE FUMARATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Abbott Medical DevicesN/A
Ball Memorial HospitalN/A
St. Jude MedicalN/A

See all IBUTILIDE FUMARATE clinical trials

Pharmacology for IBUTILIDE FUMARATE
Drug ClassAntiarrhythmic
Anatomical Therapeutic Chemical (ATC) Classes for IBUTILIDE FUMARATE

US Patents and Regulatory Information for IBUTILIDE FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090240-001 Jan 11, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Institutional IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090643-001 Jan 11, 2010 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Institutional IBUTILIDE FUMARATE ibutilide fumarate INJECTABLE;INJECTION 090924-001 Jan 11, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.